Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q1 EPS of ($0.27), $0.01 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.39 thousand.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.